The American Society of Clinical Oncology–Faculty of yank Pathologists (ASCO–CAP) suggestions have ongoing to evolve to improve the accuracy and clinical utility of HER2 testing by giving unique algorithms15,16. In parallel with existing tactics, novel ways to quantify HER2 stages or standardize processes are now being investigated, like quantitative assays https://www.directivepublications.org/journal-of-clinical-breast-cancer/